CKD Genetics: cPCA & Multi-Phenotype Analysis Boosts Loci Identification
- A recent study published in PLOS Genetics highlights the effectiveness of combinatorial principal component analysis (cPCA) in pinpointing genetic factors related to chronic kidney disease (CKD).The research suggests...
- CKD, a condition marked by a gradual decline in kidney function, arises from various causes, including hypertension, diabetes, infections, and lifestyle choices.
- Kim Ngan Tran, PhD, of the Queensland University of Technology School of Biomedical Sciences, noted that the complexity of CKD makes it tough to fully assess kidney health...
Uncover how a groundbreaking study is revolutionizing our understanding of chronic kidney disease (CKD) genetics. Using combinatorial principal component analysis (cPCA), researchers are identifying crucial genetic factors, enhancing disease classification, and possibly paving the way for new treatments. This innovative approach, detailed in our latest report, analyzed multiple biomarkers, revealing significant genetic signals missed by traditional methods. News Directory 3 dives deep into the discovery of a vital gene variant within the S2B3 gene, considerably associated with kidney function. Explore how this multi-phenotype analysis is reshaping the landscape of CKD research. Discover what’s next …
New Approach Unveils Genetic Basis of Chronic Kidney Disease
Updated june 18, 2025
A recent study published in PLOS Genetics highlights the effectiveness of combinatorial principal component analysis (cPCA) in pinpointing genetic factors related to chronic kidney disease (CKD).The research suggests that integrating multiple measurements provides a more comprehensive understanding of CKD’s genetic underpinnings, paving the way for similar approaches to tackle other complex diseases and potentially leading to new prevention and treatment strategies for chronic kidney disease.
CKD, a condition marked by a gradual decline in kidney function, arises from various causes, including hypertension, diabetes, infections, and lifestyle choices. While previous genome-wide association studies (GWAS) have identified several genetic locations linked to CKD, a significant portion of its genetic basis remains unknown. Researchers are focusing on improving the detection of genetic factors in chronic kidney disease.
Kim Ngan Tran, PhD, of the Queensland University of Technology School of Biomedical Sciences, noted that the complexity of CKD makes it tough to fully assess kidney health using a single biomarker like the estimated glomerular filtration rate (eGFR). This incomplete understanding hinders the identification of drug targets for different CKD subtypes, Tran saeid.
To address this,researchers employed cPCA,analyzing 21 CKD-related phenotypes from 337,112 individuals in a UK Biobank dataset,generating over 2 million composite phenotypes (CPs). The goal was to identify optimal biomarker combinations that improve disease classification and to find genetic locations linked to the disease.
The study found nearly 50,000 CPs with significantly higher classification power for clinical CKD compared to individual biomarkers. The top-ranked CP, a combination of albumin, cystatin C, eGFR, gamma-glutamyltransferase, hemoglobin A1c, low-density lipoprotein, and microalbuminuria, achieved a higher area under the curve (AUC) than eGFR alone. Genetic analysis of these CPs identified major eGFR-associated locations and a variant in the S2B3 gene, which was not detected using eGFR alone.
Tran said that these informative traits enabled the discovery of genetic signals that traditional methods had missed. she added that the S2B3 gene variant, previously detected only in large-scale studies, was significantly associated with kidney function using the composite traits, highlighting the power of this approach.
The authors noted that cPCA struggles to differentiate between biomarkers and causal genes. Though, they emphasized that the multi-phenotype cPCA approach enhances the understanding of CKD’s genetic basis and could be applied to other complex diseases.
Tran concluded that this study demonstrates the value of a multi-phenotype approach to understanding the genetics of CKD and could be